Reliability and Validity of Outcome Measures for Phantom Limb Pain
Launched by TEESSIDE UNIVERSITY · Jul 16, 2018
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: ≥ 18 years At least six months post amputation (date of surgery) The amputation must be above wrist/ankle. Are currently experiencing PLP which has persisted for at least 3 months or more They rate their PLP as ≥3 on a 0-10 scale on at least 2 days in the preceding week Concomitant medications;
- Exclusion Criteria:
- • Participating in any research trial of any intervention hypothesised to affect PLP.
- • Currently under-going active prosthetic rehabilitation e.g. walking training sessions or upper limb rehabilitation sessions.
- • Any current non-prescribed substance dependency An inability to understand and follow basic instructions - both the two-point discrimination test and left/right limb judgement task requires the participant to follow basic/simple instructions.
- • Any person, otherwise eligible, who commences any treatment for PLP (physical or pharmacological, prescribed or non-prescribed) will be withdrawn from the study.
About Teesside University
Teesside University is a leading higher education institution dedicated to advancing research and innovation in various fields, including healthcare and clinical studies. With a strong emphasis on collaboration and community engagement, the university fosters a dynamic environment for clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Through its state-of-the-art facilities and a multidisciplinary team of researchers, Teesside University actively supports the development and implementation of cutting-edge clinical research initiatives, ensuring adherence to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Middlesbrough, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials